News for 'Good Manufacturing Practice'

'Aim to make FAME scheme more transparent'

'Aim to make FAME scheme more transparent'

Rediff.com14 Apr 2023

'The aim is also to probe how the ministry and testing agencies made negligence in examining these OEMs, so that such negligence is avoided in the future.'

Now, Hospira under US FDA's lens

Now, Hospira under US FDA's lens

Rediff.com23 Dec 2013

Formal warning to Indian unit of deficiencies noted during inspection at facility near Chennai; firm says will remedy

Delhi air improves, but still in 'poor' category

Delhi air improves, but still in 'poor' category

Rediff.com24 Oct 2023

The city's average air quality index (AQI) stood at 220 at 12 noon, improving from 263 at 4 pm on Monday.

Campus Placements At IITs Getting Tough

Campus Placements At IITs Getting Tough

Rediff.com8 Jul 2024

Nearly 40 per cent of IITians sitting for placements in 2024 are yet to receive job offers, showing a doubling of the 'unplaced' in the last three years from 19 per cent in 2021-2022 to 38 per cent in 2023-2024.

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Rediff.com27 Feb 2014

Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.

Lapses by some pharma cos overshadowed good things: FDA chief

Lapses by some pharma cos overshadowed good things: FDA chief

Rediff.com12 Feb 2014

On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Ranbaxy sets aside Rs 257.4 cr for impact of USFDA ban

Rediff.com5 Feb 2014

Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.

We will regain confidence of the US FDA: Dilip Shanghvi

We will regain confidence of the US FDA: Dilip Shanghvi

Rediff.com26 Mar 2015

'The focus for value creation will be on all business segments.'

Before You Invest ESG Funds, Read This

Before You Invest ESG Funds, Read This

Rediff.com19 Mar 2024

An allocation to ESG theme funds can bring down the overall risk of an equity portfolio. Investors with long-term financial goals, such as retirement, should not ignore sustainable investing.

India's Chip Dreams Won't Happen Unless...

India's Chip Dreams Won't Happen Unless...

Rediff.com15 May 2023

OSAT majors have concerns about India's ability to provide a stable, predictable, and lasting policy environment for years to come, which is key for making a decision in a capital-intensive business.

'Ambani, Adani, Tata will move to Dubai if India imposes inheritance tax'

'Ambani, Adani, Tata will move to Dubai if India imposes inheritance tax'

Rediff.com8 May 2024

'Sweden removed the inheritance tax because many of the rich were fleeing. For example, the owner of IKEA had migrated out of Sweden'

US threatens to take additional action against 'unfair' Indian trade practices

US threatens to take additional action against 'unfair' Indian trade practices

Rediff.com21 Jun 2019

India has been the single biggest beneficiary of the decades-old US Generalized System of Preferences programme, allowing the country to export $ 5.7 billion worth of duty-free goods in 2017, according to figures from US Congress.

Should you buy refurbished goods online?

Should you buy refurbished goods online?

Rediff.com16 Nov 2015

Price arbitrage for popular products is low but some of these platforms are worth a look for decent deals.

Keep us in loop before any FDA swoop, India tells US

Keep us in loop before any FDA swoop, India tells US

Rediff.com11 Feb 2014

Inspections only in domestic authorities' presence, visiting US drug regulator told

Ranbaxy says its drugs are safe

Ranbaxy says its drugs are safe

Rediff.com14 Jun 2013

Ranbaxy Laboratories on Thursday said it will co-operate fully with any regulator from anywhere in the world wanting to investigate its manufacturing practices.

Why Sun Pharma stock will remain under pressure

Why Sun Pharma stock will remain under pressure

Rediff.com24 Dec 2019

The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality drug payoffs.

US says Covaxin successfully neutralises Delta variant

US says Covaxin successfully neutralises Delta variant

Rediff.com30 Jun 2021

The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2, first identified in the United Kingdom and India, respectively.

Cong promises caste survey, interest-free farm loan in Rajasthan manifesto

Cong promises caste survey, interest-free farm loan in Rajasthan manifesto

Rediff.com21 Nov 2023

The party also promised reservation to minorities on basis of their population after the caste census.

Cash crunch pain hits Dharavi's leather goods hub

Cash crunch pain hits Dharavi's leather goods hub

Rediff.com21 Dec 2016

The first of a six-part series examines how the leather workers at Dharavi are coping after five weeks of demonetisation.

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Markets come off two-month highs; Nifty ends below 8,250; IT stocks drag

Rediff.com6 Jan 2017

The BSE Midcap also cut all its intraday gains to shed 0.3% at close

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

Toxins in food? How brands can make it safer

Toxins in food? How brands can make it safer

Rediff.com6 Jun 2016

As controversy plagues foods again, brandification will bridge the trust deficit, critical for stakeholders.

Ayurveda with an allopathic twist

Ayurveda with an allopathic twist

Rediff.com2 Dec 2017

Kapiva's plans to introduce allopathy-like doses of ayurvedic remedies for the millennial consumer finds traction.

At 1.3 million, two-wheeler sales cross pre-Covid figs of September 2019

At 1.3 million, two-wheeler sales cross pre-Covid figs of September 2019

Rediff.com26 Oct 2023

The two-wheeler segment is, however, still far from its H1FY19 peak of 9.7 million units

'Thank goodness drivers bring money'

'Thank goodness drivers bring money'

Rediff.com16 Feb 2018

Williams defended their young and inexperienced Formula One drivers

The battle over product designs

The battle over product designs

Rediff.com25 Jun 2008

With rising consumerism, future feuds will be over the appearance of products.

Modi reveals names of Gaganyan mission astronauts. They are...

Modi reveals names of Gaganyan mission astronauts. They are...

Rediff.com27 Feb 2024

The four astronauts are -- Prashanth Balakrishnan Nair, Angad Prathap, Ajit Krishnan, and Shubhanshu Shukla -- Modi said at the Vikram Sarabhai Space Centre (VSSC) at Thumba near the Kerala state capital.

Sun-Ranbaxy merger may spill over to 2015

Sun-Ranbaxy merger may spill over to 2015

Rediff.com15 Nov 2014

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.

Why I Support Narayana Murthy

Why I Support Narayana Murthy

Rediff.com12 Dec 2023

If 4,000 workers could work round the clock for the construction of the new Parliament building, then there is no reason why all infrastructure projects too cannot follow that model, asserts Dr Sudhir Bisht.

PIX: India celebrates Festival of Lights

PIX: India celebrates Festival of Lights

Rediff.com12 Nov 2023

Despite the national capital recording its best air quality on Diwali day in eight years, pollution levels may rise due to low night temperatures and sporadic burning of firecrackers though there is a ban on their manufacture, storage, sale and use within the city.

Can India Be A Developed Nation By 2047?

Can India Be A Developed Nation By 2047?

Rediff.com6 Jan 2024

One hopes in his next term, Narendra Modi will take up the mission of inculcating respect for following rules in Indians as a mission. Therein lies the chance for India to become a developed country, asserts Colonel Anil A Athale (retd).

NDA Better For Economy Than INDIA In 2024

NDA Better For Economy Than INDIA In 2024

Rediff.com31 Aug 2023

What is most troubling is that not a single party that is part of INDIA has talked about any kind of reform and economic sense, argues R Jagannathan.

India Inc making workplace more inclusive for persons with disabilities

India Inc making workplace more inclusive for persons with disabilities

Rediff.com4 Dec 2023

As the world celebrated International Day of Persons with Disabilities (PwD) on December 3, corporate India has kept up with efforts to make workplaces more inclusive and accessible. Organisations across sectors are taking initiatives such as equipping offices with practical work tools like Braille-friendly and voice-enabled lifts and screen readers. While inclusion has gained pace, only 11.3 per cent (or 3.4 million out of 30 million) Indians with disabilities have jobs.

Integration challenges: Sun Pharma's next hurdle

Integration challenges: Sun Pharma's next hurdle

Rediff.com23 Apr 2015

The challenge of merging Ranbaxy into the company has not been factored in.

Delhi may see best Diwali day air quality in 8 years if...

Delhi may see best Diwali day air quality in 8 years if...

Rediff.com12 Nov 2023

This time, Delhi saw a sharp improvement in air quality just ahead of Diwali which can be attributed to intermittent rainfall on Friday and wind speed favourable for the dispersion of pollutants.

MasterChef Australia Changed Indian Food

MasterChef Australia Changed Indian Food

Rediff.com20 Oct 2023

Food in India has fled the confines of the kitchen and become a national adventure... Food shows, now even on news channels, have transformed restaurateurs from humble khansamas to courted celebrities.

How to make GST a Good Simple Tax

How to make GST a Good Simple Tax

Rediff.com21 Nov 2017

'The only way to minimise logical inconsistencies and confusion is to develop the two rates of 12% and 18% as the ones that apply to almost all items.' 'At a later stage, these two rates could be merged into a single rate,' advises T N Ninan.

M&As likely to witness a strong comeback as PEs bet more cash in India

M&As likely to witness a strong comeback as PEs bet more cash in India

Rediff.com5 Sep 2023

Mergers and acquisitions (M&As) in India are expected to stay buoyant, seen over the last three-four years, despite a slowdown in the first seven months of the calendar year. "M&A is a lumpy business activity, and we may suddenly see large deals taking place during the next two quarters of the calendar year. "This would help maintain the streak of strong M&A activity.

Here's some good news for India's tea lovers

Here's some good news for India's tea lovers

Rediff.com29 Apr 2020

Tea estates across Assam and West Bengal, which were hitherto closed owing to the lockdown, opened in April.